北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 819-823. doi: 10.3969/j.issn.1671-167X.2017.05.013

• 论著 • 上一篇    下一篇

类风湿关节炎患者髓系来源的抑制细胞促进自身B细胞增殖

陈玮1, 2, 胡凡磊1, 刘洪江1, 徐丽玲1, 李英妮1, 栗占国1   

  1. 1. 北京大学人民医院风湿免疫科,风湿病机制及免疫诊断北京市重点实验室,北京 100044;
    2.成都医学院免疫学教研室,成都 610500
  • 收稿日期:2015-12-23 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家自然科学基金(81671604、81302554、81401341)资助

Myeloid-derived suppressor cells promoted autologous B cell proliferation in rheumatoid arthritis

CHEN Wei1, 2, HU Fan-lei1, LIU Hong-jiang1, XU Li-ling1, LI Ying-ni1, LI Zhan-guo1   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital &
    Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing 100044, China;
    2.Department of Immunology, Chengdu Medical College, Chengdu 610500, China
  • Received:2015-12-23 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Natural Science Foundation of China (81671604, 81302554,81401341)

摘要: 目的 探讨类风湿关节炎(rheumatoid arthritis,RA)患者髓系来源的抑制细胞(myeloid-derived suppressor cells,MDSC)对自身B细胞增殖的影响,揭示MDSC在RA发病中的作用。方法 健康对照15例,RA患者38例,按28-关节疾病活动度分值(28-joint disease activity score,DAS28)分为高疾病活动度组(DAS28>5.1)、中疾病活动度组(3.2<DAS28≤5.1)和低疾病活动度组(2.6<DAS28≤3.2), 流式细胞术检测其外周血MDSC细胞的比例;同时分选10例高疾病活动度RA患者外周血B细胞和MDSC细胞体外共培养,羟基荧光素二醋酸盐琥珀酰亚胺酯(carboxyfluorescein diacetate succinimidyl ester,CFSE)法检测B细胞的增殖。结果 高疾病活动度RA外周血MDSC比例(7.13%±2.17%)相对于健康成年人(4.79%±1.02%)、中活动度患者(5.35%±1.36%)和低活动度患者(4.72%±1.08%)明显增加(P<0.05),而中、低疾病活动度RA之间及其二者与健康成年人之间差异皆无统计学意义(P>0.05);MDSC比例与患者DAS28分值成正相关(P<0.05),与年龄、病程、类风湿因子(rheumatoid factor,RF)、抗环瓜氨酸多肽(cyclic citrullinated peptide,CCP)抗体等无相关性;MDSC共培养不抑制反而促进B细胞的增殖(P<0.01)。结论 MDSC在高疾病活动度RA患者外周血中明显增加,与疾病活动度呈正相关,并可在体外促进自身B细胞的增殖,提示MDSC可能通过调节B细胞的功能参与RA的疾病进程。

关键词: 髓系来源的抑制细胞, 关节炎, 类风湿, B淋巴细胞, 细胞增殖

Abstract: Objective: To investigate the effect of myeloid-derived suppressor cells (MDSC) on pro-liferation of B lymphocytes in rheumatoid arthritis (RA) patients. Methods: The peripheral blood specimens were collected from 15 healthy adults and 38 RA patients who were divided into high disease activity group, medium activity group and low activity group according to their 28-joint disease activity score (DAS28). And the frequencies of MDSC were determined by flow cytometry. Then, B cells and MDSC were isolated by flow cytometry, respectively. B cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) and then were co-cultured with MDSC in the presence of 3 mg/L anti-CD40 antibody and 10 mg/L CpG, for 3 days. Flow cytometry was performed to investigate the proliferation of B cells. Results: MDSC expanded markedly in high disease activity patients (7.13%±2.17%) compared with medium (5.35%±1.36%) and low disease activity patients (4.72%±1.08%) or healthy controls (4.79%±1.02%) (P<0.05), and there were no statistical differences between healthy controls, medium and low disease activity RA (P>0.05). Moreover, the frequencies of MDSC were positively correlated with the DAS28 (P<0.05). After co-culture, MDSC significantly promoted B cell proliferation (P<0.01). Conclusion: Our studies showed that MDSC expanded obviously in high disease activity RA patients, and their frequencies were positively correlated with the disease activities. Furthermore, MDSC could promote autologous B cell proliferation remarkably in vitro. These findings suggest that MDSC might be involved in RA pathogenesis through regulating B cell functions.

Key words: Myeloid-derived suppressor cells, Arthritis, rheumatoid, B-lymphocytes, Cell proliferation

中图分类号: 

  • R593.22
[1] Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis [J]. Cell, 1996, 85(3): 307-310.
[2] Bax M, Huizinga TW, Toes RE. The pathogenic potential of autoreactive antibodies in rheumatoid arthritis [J]. Semin Immunopathol, 2014, 36(3): 313-325.
[3] Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system [J]. Nat Rev Immunol, 2009, 9(3): 162-174.
[4] Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells [J]. Immunol Rev, 2008(222): 162-179.
[5] Crook KR, Liu P. Role of myeloid-derived suppressor cells in autoimmune disease [J]. World J Immunol, 2014, 4(1): 26-33.
[6] Guo C, Hu F, Yi H, et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis [J]. Ann Rheum Dis, 2016, 75(1): 278-285.
[7] Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J]. N Engl J Med, 2004, 350(25): 2572-2581.
[8] Young MR, Newby M, Wepsic TH. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors [J]. Cancer Res, 1987, 47(1): 100-106.
[9] 许为民, 龚爱华, 王慧, 等. 类风湿关节炎患者外周血髓系来源的抑制细胞的检测及与Th1/Th2细胞的相关性分析[J]. 江苏大学学报(医学版), 2013, 23(2): 140-143.
[10] Li Y, Tu Z, Qian S, et al. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis [J]. J Immunol, 2014, 193(5): 2127-2134.
[11] Crook KR, Jin M,Weeks MF, et al. Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease [J]. J Leukoc Biol, 2015, 97(3): 573-582.
[1] 魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报(医学版), 2026, 58(2): 307-312.
[2] 吴滔, 林建子, 朱亚锋, 马剑达, 贾霈雯, 杨莉娟, 潘婕, 邹耀威, 杨迎, 卢烨, 戴冽. 血清蛋白质谱筛选及验证类风湿关节炎患者肌肉量减少的生物标志物[J]. 北京大学学报(医学版), 2025, 57(6): 1024-1031.
[3] 林文灏, 谢阳, 王芳晴, 王淑盈, 刘香君, 胡凡磊, 贾园. 基于B细胞单细胞转录组测序的干燥综合征分子分型[J]. 北京大学学报(医学版), 2025, 57(6): 1032-1041.
[4] 王翠萍, 陈哲, 程永静. 超微血流成像评估与膝骨关节炎临床症状的关联研究[J]. 北京大学学报(医学版), 2025, 57(6): 1096-1100.
[5] 吕雪冰, 俞烜华, 张伟桢, 刘昌泉, 林互涵, 曾珊婷, 黄惠娟, 吴月萍. 类风湿关节炎合并坏死性筋膜炎1例[J]. 北京大学学报(医学版), 2025, 57(6): 1198-1202.
[6] 丁艳, 王丽芳, 李超然, 卢哲敏, 石连杰. 利妥昔单抗成功治疗类风湿关节炎合并IgG4相关性疾病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1203-1207.
[7] 杨菊, 徐婧, 戴菊华, 石连杰. Lumican蛋白在类风湿关节炎患者血清中的表达及其与疾病和免疫活动的相关性[J]. 北京大学学报(医学版), 2025, 57(5): 911-918.
[8] 冯亮华, 洪丽荣, 陈雨佳, 蔡学明. 泛素特异性蛋白酶35对类风湿关节炎成纤维样滑膜细胞铁死亡的作用及机制[J]. 北京大学学报(医学版), 2025, 57(5): 919-925.
[9] 秦秋实, 李蕊, 周妍希, 张玥, 韩铭, 朱鏐娈. 敲减Blimp1基因表达对CCl4诱导的小鼠肝纤维化模型早期肝损伤的保护作用[J]. 北京大学学报(医学版), 2025, 57(4): 727-734.
[10] 贾霈雯, 杨迎, 邹耀威, 欧阳志明, 林建子, 马剑达, 杨葵敏, 戴冽. 类风湿关节炎患者低肌肉量综合征的临床特征及其对躯体功能的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1009-1016.
[11] 马豆豆, 卢哲敏, 郭倩, 朱莎, 古今, 丁艳, 石连杰. 小剂量利妥昔单抗成功治疗类风湿关节炎合并重症肌无力1例[J]. 北京大学学报(医学版), 2024, 56(6): 1110-1114.
[12] 蔡文心, 杨琼英, 韩丹, 陈哲, 程永静. 红外热成像检查在风湿病中的应用及展望[J]. 北京大学学报(医学版), 2024, 56(6): 1132-1136.
[13] 闫蕊, 柯丹, 张妍, 李丽, 苏焕然, 陈伟, 孙明霞, 刘晓敏, 罗靓. 血清趋化因子CXCL-10和涎液化糖链抗原6水平在类风湿关节炎合并肺间质病变患者中的诊断和病情评估价值[J]. 北京大学学报(医学版), 2024, 56(6): 956-962.
[14] 赵亮, 史成龙, 马柯, 赵静, 王潇, 邢晓燕, 莫万星, 练益瑞, 高超, 李玉慧. 抗合成酶综合征重叠类风湿关节炎患者的免疫学特征[J]. 北京大学学报(医学版), 2024, 56(6): 972-979.
[15] 翟佳羽, 赵金霞, 安卓, 刘蕊. 低疾病活动度的中轴型脊柱关节炎患者残留症状评估及其相关因素分析[J]. 北京大学学报(医学版), 2024, 56(6): 987-993.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!